Tempus Executive and Leadership Team

November, 2026

Leadership Overview

Tempus has 7 executives leading key functions including information technology, marketing, engineering, operations, business development, legal, and medical diagnostics.

Committed to advancing precision medicine through data-driven insights, Tempus transforms healthcare by integrating clinical and molecular data to enable highly tailored therapeutic models for patients worldwide.

Leadership Roles at Tempus

  • Chief Operating Officer, Data & Apps - Max Banaszak
  • Chief Information Officer - Natasha Esprey
  • Chief Marketing Officer - Patricia Spiller
  • Chief Technology Officer - Shane Colley
  • Business Development Director, Tempus Compass & Chief Revenue Officer, Oncology Trials, Ai & Real-World Data - Janelle Okrzesik
  • Chief Legal Officer - Andy Polovin
  • Chief Medical Officer, Diagnostics - Thomas Slavin
  • Max Banaszak - Chief Operating Officer, Data & Apps

    Max Banaszak, the Chief Operating Officer, Data & Apps at Tempus, manages the operational efficiency of the company's software applications and data processing workflows. Overseeing the internal systems that ingest and clean molecular sequencing data, the Chief Operating Officer ensures that the platform functions reliably for clinical users. This leadership role involves streamlining the integration of disparate patient records to maintain a high-performance data engine. By coordinating between engineering and laboratory teams, Max Banaszak optimizes the operational pipeline that generates patient profiles. Banaszak drives initiatives to improve system throughput, ensuring that predictive modeling tools remain accessible and responsive for medical practitioners. Through the rigorous management of application performance, the Chief Operating Officer supports the scalability of the business model, allowing the organization to process increasing volumes of clinical data while maintaining the precision required for effective therapeutic interventions.

    Natasha Esprey - Chief Information Officer

    Natasha Esprey, the Chief Information Officer at Tempus, directs the enterprise-wide digital infrastructure and data security protocols. Overseeing the integrity of massive clinical and molecular datasets, the Chief Information Officer ensures that internal systems remain compliant with global healthcare regulations while supporting high-speed computational analysis. This leadership role involves architecting scalable cloud environments that allow medical practitioners to access real-time diagnostic insights. By optimizing the flow of unstructured text from electronic health records into the proprietary data engine, Natasha Esprey directly impacts the speed and accuracy of precision medicine delivery. Esprey maintains rigorous standards for data governance, facilitating seamless collaboration between laboratory facilities and clinical partners. Through the implementation of advanced cybersecurity frameworks, the Chief Information Officer protects sensitive patient information, thereby reinforcing the trust required to scale these sophisticated diagnostic tools across diverse medical ecosystems.
    Natasha Esprey

    Patricia Spiller - Chief Marketing Officer

    Patricia Spiller, the Chief Marketing Officer at Tempus, drives the strategic positioning of the company's precision medicine platform within the global healthcare market. Overseeing brand development and outreach to clinical institutions, the Chief Marketing Officer communicates the value of integrating genomic diagnostics with predictive data modeling. This leadership role involves crafting narratives that highlight the transition from one-size-fits-all treatments to tailored therapeutic models. By analyzing market trends in oncology and cardiology, Patricia Spiller identifies key opportunities for expanding the reach of the proprietary data engine. Spiller collaborates with product teams to ensure that messaging aligns with the technical capabilities of the platform, effectively bridging the gap between complex algorithmic analysis and the needs of medical practitioners. Through targeted campaigns, the Chief Marketing Officer accelerates the adoption of these advanced diagnostic solutions, ultimately expanding the footprint of the organization across international medical communities.
    Patricia Spiller

    Shane Colley - Chief Technology Officer

    Shane Colley, the Chief Technology Officer at Tempus, architects the core neural networks and predictive modeling systems that power the company's diagnostic platform. Overseeing the engineering teams responsible for normalizing vast amounts of unstructured clinical data, the Chief Technology Officer ensures the platform identifies hidden genetic patterns and therapeutic correlations with high precision. This leadership role involves pushing the boundaries of machine learning to forecast how specific pathologies react to diverse chemical interventions. By refining the computational engine, Shane Colley directly enables medical practitioners to make data-informed decisions for oncology and neuropsychiatry patients. Colley maintains a focus on technical innovation, ensuring the platform remains at the forefront of genomic diagnostics. Through the continuous development of advanced algorithms, the Chief Technology Officer supports the company's mission to unify disparate patient histories into comprehensive, multimodal profiles that drive superior clinical outcomes.
    Shane Colley

    Janelle Okrzesik - Business Development Director, Tempus Compass & Chief Revenue Officer, Oncology Trials, Ai & Real-World Data

    Janelle Okrzesik, the Business Development Director, Tempus Compass & Chief Revenue Officer, Oncology Trials, Ai & Real-World Data at Tempus, leads the commercial expansion of the company's oncology and real-world data initiatives. Overseeing partnerships with pharmaceutical companies and research institutions, the Chief Revenue Officer secures revenue streams by demonstrating the utility of the platform in clinical trials. This leadership role involves identifying new market segments where algorithmic analysis can transform patient care. By aligning business development strategies with the company's diagnostic capabilities, Janelle Okrzesik drives the adoption of precision medicine tools in oncology. Okrzesik manages complex negotiations and long-term collaborations, ensuring that the organization remains a preferred partner for data-driven research. Through the strategic deployment of real-world data insights, the Chief Revenue Officer supports the growth of the business, ultimately expanding the impact of the platform on therapeutic development and patient outcomes.
    Andy Polovin, the Chief Legal Officer at Tempus, directs the legal strategy and regulatory compliance framework for the company's operations. Overseeing intellectual property protection and data privacy standards, the Chief Legal Officer ensures that the organization navigates the complex regulatory landscape of genomic diagnostics and clinical data science. This leadership role involves managing legal risks associated with the use of patient health records and the deployment of artificial intelligence in medical settings. By providing counsel on corporate governance and strategic partnerships, Andy Polovin enables the business to scale its operations while adhering to strict healthcare laws. Polovin maintains a focus on protecting the proprietary technology that defines the company's market position. Through the proactive management of legal affairs, the Chief Legal Officer supports the company's mission to transform healthcare, ensuring that all innovations remain compliant and secure within the global medical ecosystem.
    Andy Polovin

    Thomas Slavin - Chief Medical Officer, Diagnostics

    Thomas Slavin, the Chief Medical Officer, Diagnostics at Tempus, leads the clinical strategy for the company's diagnostic laboratory facilities and genomic sequencing services. Overseeing the medical validity of the platform's outputs, the Chief Medical Officer ensures that the integration of molecular data with clinical history provides actionable insights for practitioners. This leadership role involves guiding the development of new diagnostic tests that identify hidden genetic patterns in oncology and infectious diseases. By bridging the gap between laboratory science and clinical application, Thomas Slavin enables doctors to transition toward precision-based therapeutic models. Slavin collaborates with research teams to validate the predictive accuracy of the platform, ensuring that diagnostic results directly improve patient care. Through the oversight of clinical standards, the Chief Medical Officer maintains the scientific integrity of the organization, driving the adoption of advanced diagnostics across the healthcare industry.
    Thomas Slavin

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding Tempus Top Executives and Leadership Team

    Who leads Tempus?
    Tempus is led by Max Banaszak (Chief Operating Officer, Data & Apps), along with executives such as Natasha Esprey (Chief Information Officer) and Patricia Spiller (Chief Marketing Officer).
    Who is part of Tempus’s executive team?
    The executive team of Tempus includes leaders such as Max Banaszak (Chief Operating Officer, Data & Apps), Natasha Esprey (Chief Information Officer), Patricia Spiller (Chief Marketing Officer) and other senior executives.
    How many executives does Tempus have?
    Tempus has 7 executives leading key business areas.
    What roles are included in Tempus’s leadership team?
    The leadership team of Tempus includes roles such as Chief Operating Officer, Data & Apps, Chief Information Officer, Chief Marketing Officer, Chief Technology Officer, Business Development Director, Tempus Compass & Chief Revenue Officer, Oncology Trials, Ai & Real-World Data.